Latest Restructuring News

RLF AgTech Ltd has reported a record December quarter with $10.4 million in cash receipts, driven by strong performances across its LiquaForce, China, and newly operational Australian divisions. Positive field trial results in Vietnam and ongoing expansion in Southeast Asia underpin the company’s growth outlook.

Waratah Minerals reports robust drilling results at its Spur gold project and launches an ambitious 80,000-metre drilling campaign in 2026, backed by a solid $28.6 million cash position.

Global Lithium Resources has released a strong Definitive Feasibility Study for its Manna Lithium Project, confirming its economic resilience, while also initiating an IPO to spin out its Marble Bar gold assets.

Assetora Limited has announced a $4 million pro-rata rights issue priced at $0.16 per share, with half the offer underwritten by existing shareholders to strengthen its balance sheet and repay debt.

Pilot Energy is seeking shareholder approval for a 1-for-25 consolidation of its securities to streamline its capital structure and boost investor appeal as it advances into carbon storage and clean energy projects.

ReadCloud Limited has secured over 50 new school contracts for 2026, driving strong growth in its VET-in-Schools and eBooks divisions despite ongoing funding challenges in its Industry Training segment.

Visionflex Group Limited reported a mixed quarter with a modest cash burn but strengthened its balance sheet through a significant debt-to-equity conversion and maintained solid funding capacity.

Visionflex Group’s Q2 FY26 report reveals a 23% rise in annual recurring revenue and improved cash flow, even as overall revenue slips due to lower hardware sales.

Aura Energy has attracted a C$10 million investment from MMCAP and strategic partners, valuing its Swedish Häggån polymetallic project at C$50 million and spinning it into a new Canadian-listed entity.

Light & Wonder, Inc. has amended its credit agreement to introduce a new $2.13 billion tranche of term loans due in 2029, replacing prior debt and reducing borrowing costs. The move reflects a strategic refinancing amid its Nasdaq delisting process.

Invex Therapeutics reports promising new data from its collaboration with Tessara Therapeutics on Exenatide’s potential in Alzheimer’s disease, alongside significant board changes and a solid cash position at quarter’s end.

Memphasys Limited has achieved its first material revenues following CE Mark approval for its Felix™ System, activating multi-year contracts across Europe, the Middle East, and Asia. The company is now transitioning from regulatory preparation to global commercial rollout with a focus on recurring revenues.